EVMN
Evommune, Inc.
There isn't enough reported data to score EVMN yet.
EVMN Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
EVMN's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
EVMN PE Valuation
EVMN has no meaningful PE right now: it lost money over the past year.
EVMN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EVMN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
EVMN Earnings Per Share
EVMN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2025 | $3M | -57% |
EVMN's revenue has slid since its 2025 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -133% | N/A |
| Q1 2025 | -501% | -447 points |
| Q1 2024 | -54% | N/A |
EVMN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$20.5M | +$5.7M |
| Q1 2026 | -$27.6M | -$3.7M |
| Q4 2025 | -$16.8M | +$1.7M |
| Q2 2025 | -$26.2M | -$17.6M |
| Q1 2025 | -$23.9M | -$19M |
EVMN has burned cash in almost every quarter: −$91M over the past year, against −$95M the year before.
EVMN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
EVMN has 30M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
EVMN hasn't bought back shares in the past year.
EVMN Net Leverage
EVMN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EVMN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.2 | Neutral |
| Stochastic | 21.7 | Neutral |
EVMN's weekly RSI is 38 (neutral) and its Stochastic is 22 (neutral).
EVMN PE vs Healthcare Sector
EVMN has no meaningful PE right now: it lost money over the past year.
EVMN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.67 | 20% above |
| 20 week MA | $10.1 | 21% below |
| 50 week MA | $17.4 | 54% below |
EVMN has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 54% below its 50-week average.
EVMN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $18.4 | $17.2 | -6.5% |
| 2026 YTD | $17.2 | $8.02 | -53% |
EVMN has finished every year since 2025 lower, and it's down 53% so far in 2026.